Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Sky News covering it now.
http://news.sky.com/story/covid-19-t-cell-discovery-may-lead-to-vaccine-that-targets-all-coronaviruses-and-variants-study-finds-12465761
https://www.jobs.ac.uk/job/CHE851/mrc-impact-dtp-icase-phd-studentship
If anyone is interested in applying:
https://gb.melga.com/job/2021-07-07_e87075a2d39b3d732304f202c9bcf114
Just noticed the
"Development of an inhaled DNA vaccine". Has this been mentioned before on here? Thought it might be of interest.
Reference SCI2022 Closing Date Saturday, 31st July 2021 Department Pharmacy
Supervisors: James Dixon (School of Pharmacy), with Scancell (SME)
Development of an intradermal or inhaled DNA vaccine for COVID-19 and beyond
Intradermal and inhaled delivery of nucleic acid vaccines could be clinically effective, safe and globally-deployable against multiple complex diseases. This project will aim to combine physical and peptide-based delivery systems to enhance the efficacy and application of such technologies to the COVID-19 vaccine ('Covidity') presently under-development by our consortium (funded by Innovate-UK). This PhD will formulate and test combined systems for skin and lung-focused vaccine delivery in ex vivo tissue models, then move to rodent models, examining virus neutralisation, T cell responses and protection in virally challenged animals. The platform technology optimised and demonstrated will have wide ranging impact on future applications of nucleic acid vaccine approaches (including DNA, mRNA and oligo-based methods). The PhD will also directly aid attempts to translate antibody and peptide-engineering knowhow to generate a rapidly deployable and safe immunisation system for multiple complex diseases.
Please email to discuss the project; this is vital for a successful application:
James.dixon@nottingham.ac.uk
EU regulator reviewing possible links between Johnson & Johnson jab and blood clots.
https://www.google.com/amp/s/news.sky.com/story/amp/eu-regulator-reviewing-possible-links-between-johnson-johnson-jab-and-blood-clots-12270444
https://www.reuters.com/article/health-coronavirus-britain-vaccine/uk-earmarks-a-further-2-3-bln-for-its-covid-vaccine-push-idUSL5N2KY0AZ
"A further 33 million pounds will be spent on vaccine testing and development to protect against future outbreaks and variants and 22 million pounds will fund a study to test the effectiveness of combinations of different COVID-19 vaccines."
We are tested monthly on this large construction site in Ireland where I work.
The test is performed by Randox and the test performed is on the ORF1ab and E gene.
What I am wondering, how robust is this test?
Would this test cover all known variants or would it be likely to miss a new variant?
Here is a nice explanation of the Spike protein, Envelope protein and Nucleocapsid from UC Davis
https://health.ucdavis.edu/blog/lab-best-practice/the-sars-cov-2-variant-and-its-impact-on-diagnostic-testing/2021/01